Cleared Traditional

K222631 - VASSALLO GT EXT (FDA 510(k) Clearance)

Oct 2022
Decision
56d
Days
Class 2
Risk

K222631 is an FDA 510(k) clearance for the VASSALLO GT EXT. This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).

Submitted by Filmecc Co., Ltd. (Hagoya-Shi, JP). The FDA issued a Cleared decision on October 26, 2022, 56 days after receiving the submission on August 31, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K222631 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 2022
Decision Date October 26, 2022
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQX - Wire, Guide, Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330

Similar Devices - DQX Wire, Guide, Catheter

All 27
FMD Peripheral Guide Wire F-14 Flex 6
K260544 · FMD Co., Ltd. · Mar 2026
Enroute 0.014'' Transcarotid Guidewire
K253746 · Lake Region Medical · Mar 2026
EmeryGlide™ (EG18008901)
K253262 · Nano4imaging GmbH · Mar 2026
Splashwire Hydrophilic Guide Wire (MSWSTD35150J3)
K253847 · Merit Medical Ireland, Ltd. · Jan 2026
InQwire Super Stiff Guide Wire (IQSS32180J3)
K251385 · Merit Medical Ireland, Ltd. · Jan 2026
Solo Pace Fusion System (SOLOFUSE1)
K252674 · Solo Pace, Inc. · Jan 2026